# Multihance Versus Magnevist in Breast MRI

> **NCT00486473** · PHASE3 · COMPLETED · sponsor: **Bracco Diagnostics, Inc** · enrollment: 130 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Multihance
- **DRUG:** Magnevist

## Key facts

- **NCT ID:** NCT00486473
- **Lead sponsor:** Bracco Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2010-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486473, "Multihance Versus Magnevist in Breast MRI". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00486473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*